<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2021-04-07" version="97">
<accession>Q55012</accession>
<accession>E3VWK6</accession>
<name>PENA_STREX</name>
<protein>
<recommendedName>
<fullName>Pentalenene synthase</fullName>
<shortName>PS</shortName>
<ecNumber>4.2.3.7</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Pentalenolactone biosynthesis protein A</fullName>
</alternativeName>
<alternativeName>
<fullName>Sesquiterpene cyclase</fullName>
</alternativeName>
<alternativeName>
<fullName>Sesquiterpene synthase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">penA</name>
</gene>
<organism>
<name type="scientific">Streptomyces exfoliatus</name>
<name type="synonym">Streptomyces hydrogenans</name>
<dbReference type="NCBI Taxonomy" id="1905"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Actinobacteria</taxon>
<taxon>Streptomycetales</taxon>
<taxon>Streptomycetaceae</taxon>
<taxon>Streptomyces</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Biochemistry" volume="33" first="5846" last="5857">
<title>Pentalenene synthase. Purification, molecular cloning, sequencing, and high-level expression in Escherichia coli of a terpenoid cyclase from Streptomyces UC5319.</title>
<authorList>
<person name="Cane D.E."/>
<person name="Sohng J.-K."/>
<person name="Lamberson C.R."/>
<person name="Rudnicki S.M."/>
<person name="Wu Z."/>
<person name="Lloyd M.D."/>
<person name="Oliver J.S."/>
<person name="Hubbard B.R."/>
</authorList>
<dbReference type="PubMed" id="8180213"/>
<dbReference type="DOI" id="10.1021/bi00185a024"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>PROTEIN SEQUENCE OF 2-28; 57-73; 96-120 AND 145-157</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>COFACTOR</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<source>
<strain>UC5319</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2011" name="J. Am. Chem. Soc." volume="133" first="2128" last="2131">
<title>Genome mining in streptomyces. Discovery of an unprecedented P450-catalyzed oxidative rearrangement that is the final step in the biosynthesis of pentalenolactone.</title>
<authorList>
<person name="Zhu D."/>
<person name="Seo M.J."/>
<person name="Ikeda H."/>
<person name="Cane D.E."/>
</authorList>
<dbReference type="PubMed" id="21284395"/>
<dbReference type="DOI" id="10.1021/ja111279h"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>UC5319</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="J. Am. Chem. Soc." volume="121" first="591" last="592">
<title>Pentalenene synthase. Histidine-309 is not required for catalytic activity.</title>
<authorList>
<person name="Seemann M."/>
<person name="Zhai G."/>
<person name="Umezawa K."/>
<person name="Cane D.E."/>
</authorList>
<dbReference type="DOI" id="10.1021/ja983657h"/>
</citation>
<scope>MUTAGENESIS OF HIS-309</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Science" volume="277" first="1820" last="1824">
<title>Crystal structure of pentalenene synthase: mechanistic insights on terpenoid cyclization reactions in biology.</title>
<authorList>
<person name="Lesburg C.A."/>
<person name="Zhai G."/>
<person name="Cane D.E."/>
<person name="Christianson D.W."/>
</authorList>
<dbReference type="PubMed" id="9295272"/>
<dbReference type="DOI" id="10.1126/science.277.5333.1820"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="J. Am. Chem. Soc." volume="124" first="7681" last="7689">
<title>Pentalenene synthase. Analysis of active site residues by site-directed mutagenesis.</title>
<authorList>
<person name="Seemann M."/>
<person name="Zhai G."/>
<person name="de Kraker J.-W."/>
<person name="Paschall C.M."/>
<person name="Christianson D.W."/>
<person name="Cane D.E."/>
</authorList>
<dbReference type="PubMed" id="12083921"/>
<dbReference type="DOI" id="10.1021/ja026058q"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF MUTANT LEU-219</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF PHE-76; PHE-77; ASP-80; ASP-81; ASP-84; ASN-219; 308-TRP-HIS-309; TRP-308 AND HIS-309</scope>
</reference>
<comment type="function">
<text evidence="3">Catalyzes the cyclization of farnesyl diphosphate (FPP) to the tricyclic sesquiterpene pentalenene, which is the hydrocarbon precursor of the pentalenolactone family of antibiotics produced by a variety of Streptomyces species.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="2">
<text>(2E,6E)-farnesyl diphosphate = diphosphate + pentalenene</text>
<dbReference type="Rhea" id="RHEA:18081"/>
<dbReference type="ChEBI" id="CHEBI:17251"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:175763"/>
<dbReference type="EC" id="4.2.3.7"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="1">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<text evidence="1">Binds 3 Mg(2+) ions per subunit.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="3">310 nM for FPP</KM>
</kinetics>
<phDependence>
<text evidence="3">Optimum pH is 8.2-8.4.</text>
</phDependence>
</comment>
<comment type="pathway">
<text>Sesquiterpene biosynthesis; pentalenene biosynthesis; pentalenene from farnesyl diphosphate: step 1/1.</text>
</comment>
<comment type="pathway">
<text>Antibiotic biosynthesis; pentalenolactone biosynthesis.</text>
</comment>
<comment type="subunit">
<text evidence="3">Monomer.</text>
</comment>
<comment type="domain">
<text>The Asp-Asp-Xaa-Xaa-Asp/Glu (DDXXD/E) motif is important for the catalytic activity, presumably through binding to Mg(2+).</text>
</comment>
<comment type="miscellaneous">
<text>All the mutants (Ref.3 and PubMed:12083921) retained substantial pentalenene synthase activity accompanied by production of varying proportions of abortive cyclization products such as germacrene A, protoilludene and beta-caryophyllene. This is a true derailment or diversion of the normal cyclization reaction, and not simply the consequence of trapping of a normally cryptic, cationic intermediate.</text>
</comment>
<comment type="similarity">
<text evidence="5">Belongs to the terpene synthase family.</text>
</comment>
<dbReference type="EC" id="4.2.3.7"/>
<dbReference type="EMBL" id="U05213">
<property type="protein sequence ID" value="AAA19131.1"/>
<property type="molecule type" value="Unassigned_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ292066">
<property type="protein sequence ID" value="ADO85594.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PDB" id="1HM4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.47"/>
<property type="chains" value="A/B=2-337"/>
</dbReference>
<dbReference type="PDB" id="1HM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=2-337"/>
</dbReference>
<dbReference type="PDB" id="1PS1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDB" id="6WKJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-337"/>
</dbReference>
<dbReference type="PDBsum" id="1HM4"/>
<dbReference type="PDBsum" id="1HM7"/>
<dbReference type="PDBsum" id="1PS1"/>
<dbReference type="PDBsum" id="6WKC"/>
<dbReference type="PDBsum" id="6WKD"/>
<dbReference type="PDBsum" id="6WKE"/>
<dbReference type="PDBsum" id="6WKF"/>
<dbReference type="PDBsum" id="6WKG"/>
<dbReference type="PDBsum" id="6WKH"/>
<dbReference type="PDBsum" id="6WKI"/>
<dbReference type="PDBsum" id="6WKJ"/>
<dbReference type="SMR" id="Q55012"/>
<dbReference type="BioCyc" id="MetaCyc:MONOMER-16834"/>
<dbReference type="BRENDA" id="4.2.3.7">
<property type="organism ID" value="22521"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00171">
<property type="reaction ID" value="UER00581"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00974"/>
<dbReference type="EvolutionaryTrace" id="Q55012"/>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050467">
<property type="term" value="F:pentalenene synthase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0017000">
<property type="term" value="P:antibiotic biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.600.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008949">
<property type="entry name" value="Isoprenoid_synthase_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034686">
<property type="entry name" value="Terpene_cyclase-like_2"/>
</dbReference>
<dbReference type="SFLD" id="SFLDG01020">
<property type="entry name" value="Terpene_Cyclase_Like_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48576">
<property type="entry name" value="SSF48576"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0045">Antibiotic biosynthesis</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<feature type="initiator methionine" description="Removed" evidence="3">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Pentalenene synthase" id="PRO_0000097092">
<location>
<begin position="2"/>
<end position="337"/>
</location>
</feature>
<feature type="short sequence motif" description="DDXXD motif">
<location>
<begin position="80"/>
<end position="84"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1">
<location>
<position position="80"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2">
<location>
<position position="80"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1">
<location>
<position position="84"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2">
<location>
<position position="84"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 3">
<location>
<position position="219"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 3" evidence="1">
<location>
<position position="223"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 3" evidence="1">
<location>
<position position="227"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="128"/>
<end position="136"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="2">
<original>F</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="2">
<original>F</original>
<variation>A</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="mutagenesis site" description="20-fold decrease in activity and catalytic efficiency." evidence="2">
<original>F</original>
<variation>Y</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="mutagenesis site" description="150-fold decrease in activity. 20-fold increase in Km for FPP." evidence="2">
<original>D</original>
<variation>E</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="mutagenesis site" description="50-fold decrease in activity. 9-fold increase in Km for FPP." evidence="2">
<original>D</original>
<variation>E</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="2.5-fold increase in activity. 7-fold increase in Km for FPP." evidence="2">
<original>D</original>
<variation>E</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="2">
<original>N</original>
<variation>A</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="60-fold decrease in activity. 55-fold increase in Km for FPP." evidence="2">
<original>N</original>
<variation>D</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="2">
<original>N</original>
<variation>L</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="12-fold decrease in activity. 25-fold decrease in catalytic efficiency." evidence="2">
<original>WH</original>
<variation>FF</variation>
<location>
<begin position="308"/>
<end position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="4-fold decrease in activity. 2-fold decrease in catalytic efficiency." evidence="2">
<original>W</original>
<variation>F</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold decrease in activity." evidence="2 4">
<original>H</original>
<variation>A</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="4-fold decrease in activity." evidence="2 4">
<original>H</original>
<variation>C</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="17-fold decrease in activity. 5-fold increase in Km for FPP." evidence="2 4">
<original>H</original>
<variation>F</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold decrease in activity." evidence="2 4">
<original>H</original>
<variation>S</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AA sequence." ref="1" evidence="5">
<original>H</original>
<variation>W</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="19"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="28"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="39"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="50"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="64"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="86"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="91"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="103"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="115"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="133"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="166"/>
<end position="176"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="179"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="202"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="224"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="236"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="248"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="284"/>
<end position="296"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="298"/>
<end position="308"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="309"/>
<end position="311"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12083921"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8180213"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="5" type="ECO:0000305"/>
<evidence key="6" type="ECO:0007744">
<source>
<dbReference type="PDB" id="1PS1"/>
</source>
</evidence>
<sequence length="337" mass="38002" checksum="417FCE6D8C4BB18C" modified="2007-01-23" version="4">MPQDVDFHIPLPGRQSPDHARAEAEQLAWPRSLGLIRSDAAAERHLRGGYADLASRFYPHATGADLDLGVDLMSWFFLFDDLFDGPRGENPEDTKQLTDQVAAALDGPLPDTAPPIAHGFADIWRRTCEGMTPAWCARSARHWRNYFDGYVDEAESRFWNAPCDSAAQYLAMRRHTIGVQPTVDLAERAGRFEVPHRVFDSAVMSAMLQIAVDVNLLLNDIASLEKEEARGEQNNMVMILRREHGWSKSRSVSHMQNEVRARLEQYLLLESCLPKVGEIYQLDTAEREALERYRTDAVRTVIRGSYDWHRSSGRYDAEFALAAGAQGYLEELGSSAH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>